Thioredoxin-interacting protein expression is required for VEGF-mediated angiogenic signal in endothelial cells

Antioxidants and Redox Signaling

Volumn 19, Issue 18, 2013, Pages 2199-2212

  Abdelsaid, Mohammed A ^a,b,c   Matragoon, Suraporn ^a,b,c   El Remessy, Azza B ^a,b,c  

^a UNIVERSITY OF GEORGIA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; GLUTATHIONE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PROTEIN TYROSINE PHOSPHATASE; THIOREDOXIN INTERACTING PROTEIN; THIOREDOXIN REDUCTASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOPHOSPHORYLATION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENE SILENCING; HYPEROXIA; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; MICROVASCULAR ENDOTHELIAL CELL; MOLECULAR WEIGHT; MOUSE; NERVE SPROUTING; NEWBORN; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RETINA NEOVASCULARIZATION; SIGNAL TRANSDUCTION; VASCULAR RING;

ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; ENDOTHELIAL CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; THIOREDOXINS; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 84890505650     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4761     Document Type: Article

References (53)

1. Abdelsaid MA and El-Remessy AB. S-glutathionylation of LMW-PTP regulates VEGF-mediated FAK activation and endothelial cell migration. J Cell Sci 125: 4751-4760, 2012.
2. This reference has been deleted.
3. Abdelsaid MA, Pillai BA, Matragoon S, Prakash R, Al-Shabrawey M, and El-Remessy AB. Early intervention of tyrosine nitration prevents vaso-obliteration and neovascularization in ischemic retinopathy. J Pharmacol Exp Ther 332: 125-134, 2010.
4. This reference has been deleted.
5. Abo-Auda W and Benza RL. Therapeutic angiogenesis: Review of current concepts and future directions. J Heart Lung Transplant 22: 370-382, 2003.
6. Adluri RS, Thirunavukkarasu M, Zhan L, Akita Y, Samuel SM, Otani H, Ho YS, Maulik G, and Maulik N. Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: A study using thioredoxin 1 transgenic mice. J Mol Cell Cardiol 50: 239-247, 2011.
7. Al-Gayyar MM, Abdelsaid MA, Matragoon S, Pillai BA, and El-Remessy AB. Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity. Br J Pharmacol 164: 170-180, 2011.
8. Al-Shabrawey M, Bartoli M, El-Remessy AB, Platt DH, Matragoon S, Behzadian MA, Caldwell RW, and Caldwell RB. Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy. Am J Pathol 167: 599-607, 2005.
9. Beauchamp MH, Sennlaub F, Speranza G, Gobeil F, Jr., Checchin D, Kermorvant-Duchemin E, Abran D, Hardy P, Lachapelle P, Varma DR, and Chemtob S. Redox-dependent effects of nitric oxide on microvascular integrity in oxygeninduced retinopathy. Free Radic Biol Med 37: 1885-1894, 2004.
10. Bhattacharya R, Kwon J, Wang E, Mukherjee P, and Mukhopadhyay D. Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migration. J Mol Signal 3: 8, 2008.
11. Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH, Liou GI, and Caldwell RW. Vascular endothelial growth factor and diabetic retinopathy: Role of oxidative stress. Curr Drug Targets 6: 511-524, 2005.
12. Carmeliet P. Angiogenesis in health and disease. Nat Med 9: 653-660, 2003.
13. Cha-Molstad H, Saxena G, Chen J, and Shalev A. Glucosestimulated expression of Txnip is mediated by carbohydrate response element-binding protein, p300, and histone H4 acetylation in pancreatic beta cells. J Biol Chem 284: 16898-16905, 2009.
14. Chiarugi P. PTPs versus PTKs: The redox side of the coin. Free Radic Res 39: 353-364, 2005.
15. Colavitti R, Pani G, Bedogni B, Anzevino R, Borrello S, Waltenberger J, and Galeotti T. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem 277: 3101-3108, 2002.
16. Connor KM, Krah NM, Dennison RJ, Aderman CM, Chen J, Guerin KI, Sapieha P, Stahl A, Willett KL, and Smith LE. Quantification of oxygen-induced retinopathy in the mouse: A model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc 4: 1565-1573, 2009.
17. Dai S, He Y, Zhang H, Yu L, Wan T, Xu Z, Jones D, Chen H, and Min W. Endothelial-specific expression of mitochondrial thioredoxin promotes ischemia-mediated arteriogenesis and angiogenesis. Arterioscler Thromb Vasc Biol 29: 495-502, 2009.
18. Dunn LL, Buckle AM, Simpson P, Sieveking DP, Chow RW, Lim P, Ng and MKC. Rescue of diabetes-related impairment of angiogenesis by gene silencing of thioredoxin-interacting protein. Circulation 120: S1142, 2010.
19. Dunn LL, Buckle AM, Cooke JP, and Ng MK. The emerging role of the thioredoxin system in angiogenesis. Arterioscler Thromb Vasc Biol 30: 2089-2098, 2010.
20. El-Remessy AB, Al-Shabrawey M, Platt DH, Bartoli M, Behzadian MA, Ghaly N, Tsai N, Motamed K, and Caldwell RB. Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent mechanism in endothelial cells. Faseb J 21: 2528-2539, 2007.
21. Farrell MR, Rogers LK, Liu Y, Welty SE, and Tipple TE. Thioredoxin-interacting protein inhibits hypoxia-inducible factor transcriptional activity. Free Radic Biol Med 49: 1361-1367, 2010.
22. Ferrara N. Vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 29: 789-791, 2009.
23. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, and Moore MW. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442, 1996.
24. Folkman J. Angiogenesis. Annu Rev Med 57: 1-18, 2006.
25. Giannoni E, Chiarugi P, Cozzi G, Magnelli L, Taddei ML, Fiaschi T, Buricchi F, Raugei G, and Ramponi G. Lymphocyte function-associated antigen-1-mediated T cell adhesion is impaired by low molecular weight phosphotyrosine phosphatase-dependent inhibition of FAK activity. J Biol Chem 278: 36763-36776, 2003.
26. Huang L, Sankar S, Lin C, Kontos CD, Schroff AD, Cha EH, Feng SM, Li SF, Yu Z, Van Etten RL, Blanar MA, and Peters KG. HCPTPA, a protein tyrosine phosphatase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity. J Biol Chem 274: 38183-38188, 1999.
27. Hui ST, Andres AM, Miller AK, Spann NJ, Potter DW, Post NM, Chen AZ, Sachithanantham S, Jung DY, Kim JK, and Davis RA. Txnip balances metabolic and growth signaling via PTEN disulfide reduction. Proc Natl Acad Sci USA 105: 3921-3926, 2008.
28. Hui TY, Sheth SS, Diffley JM, Potter DW, Lusis AJ, Attie AD, and Davis RA. Mice lacking thioredoxin-interacting protein provide evidence linking cellular redox state to appropriate response to nutritional signals. J Biol Chem 279: 24387-24393, 2004.
29. Kang DH, Lee DJ, Lee KW, Park YS, Lee JY, Lee SH, Koh YJ, Koh GY, Choi C, Yu DY, Kim J, and Kang SW. Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells. Mol Cell 44: 545-558, 2011.
30. Kaplan N, Urao N, Furuta E, Kim SJ, Razvi M, Nakamura Y, McKinney RD, Poole LB, Fukai T, and Ushio-Fukai M. Localized cysteine sulfenic acid formation by vascular endothelial growth factor: Role in endothelial cell migration and angiogenesis. Free Radic Res 45: 1124-1135, 2011.
31. Kim WJ, Cho H, Lee SW, Kim YJ, and Kim KW. Antisensethioredoxin inhibits angiogenesis via pVHL-mediated hypoxiainducible factor-1alpha degradation. Int J Oncol 26: 1049-1052, 2005.
32. Kozak A, Ergul A, El-Remessy AB, Johnson MH, Machado LS, Elewa HF, Abdelsaid M, Wiley DC, and Fagan SC. Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke. Stroke 40: 1870-1876, 2009.
33. Langston W, Chidlow JH, Jr., Booth BA, Barlow SC, Lefer DJ, Patel RP, and Kevil CG. Regulation of endothelial glutathione by ICAM-1 governs VEGF-A-mediated eNOS activity and angiogenesis. Free Radic Biol Med 42: 720-729, 2007.
34. Masutani H, Yoshihara E, Masaki S, Chen Z, and Yodoi J. Thioredoxin binding protein (TBP)-2/Txnip and alphaarrestin proteins in cancer and diabetes mellitus. J Clin Biochem Nutr 50: 23-34, 2012.
35. Mellberg S, Dimberg A, Bahram F, Hayashi M, Rennel E, Ameur A, Westholm JO, Larsson E, Lindahl P, Cross MJ, and Claesson-Welsh L. Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis. FASEB J 23: 1490-1502, 2009.
36. Meyer Y, Buchanan BB, Vignols F, and Reichheld JP. Thioredoxins and glutaredoxins: Unifying elements in redox biology. Annu Rev Genet 43: 335-367, 2009.
37. Mitola S, Brenchio B, Piccinini M, Tertoolen L, Zammataro L, Breier G, Rinaudo MT, Den Hertog J, Arese M, and Bussolino F. Type I collagen limits VEGFR-2 signaling by a SHP2 protein-tyrosine phosphatase-dependent mechanism Circ Res 98: 45-54, 2006.
38. Munoz-Chapuli R, Quesada AR, and Angel Medina M. Angiogenesis and signal transduction in endothelial cells. Cell Mol Life Sci 61: 2224-2243, 2004.
39. Nicosia RF, Lin YJ, Hazelton D, and Qian X. Endogenous regulation of angiogenesis in the rat aorta model. Role of vascular endothelial growth factor. Am J Pathol 151: 1379-1386, 1997.
40. Park Y, Park SY, Shi X, Pang J, Yan C, and Berk BC. Thioredoxin- interacting protein mediates sustained VEGFR2 signaling in endothelial cells required for angiogenesis. Arterioscler Thromb Vasc Biol 33: 737-743, 2013.
41. Patwari P, Higgins LJ, Chutkow WA, Yoshioka J, and Lee RT. The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange. J Biol Chem 281: 21884-21891, 2006.
42. Perrone L, Devi TS, Hosoya K, Terasaki T, and Singh LP. Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions. J Cell Physiol 221: 262-272, 2009.
43. Piao ZH, Yoon SR, Kim MS, Jeon JH, Lee SH, Kim TD, Lee HG, Bae KH, Min JK, Chung SJ, Kim M, Cho YS, Oh DB, Park SY, Chung JW, and Choi I. VDUP1 potentiates Ras-mediated angiogenesis via ROS production in endothelial cells. Cell Mol Biol (Noisy-le-grand) 55 Suppl: OL1096-OL1103, 2009.
44. Sheth SS, Castellani LW, Chari S, Wagg C, Thipphavong CK, Bodnar JS, Tontonoz P, Attie AD, Lopaschuk GD, and Lusis AJ. Thioredoxin-interacting protein deficiency disrupts the fastingfeeding metabolic transition. J Lipid Res 46: 123-134, 2005.
45. Smith LE, Wesolowski E,McLellan A, Kostyk SK, D'Amato R, Sullivan R, and D'Amore PA. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35: 101-111, 1994.
46. Tajima M, Kurashima Y, Sugiyama K, Ogura T, and Sakagami H. The redox state of glutathione regulates the hypoxic induction of HIF-1. Eur J Pharmacol 606: 45-49, 2009.
47. Testa U, Pannitteri G, and Condorelli GL. Vascular endothelial growth factors in cardiovascular medicine. J Cardiovasc Med (Hagerstown) 9: 1190-1221, 2008.
48. Uchida C and Haas TL. Evolving strategies in manipulating VEGF/VEGFR signaling for the promotion of angiogenesis in ischemic muscle. Curr Pharm Des 15: 411-421, 2009.
49. Ushio-Fukai M. Redox signaling in angiogenesis: Role of NADPH oxidase. Cardiovasc Res 71: 226-235, 2006.
50. Welsh SJ, Bellamy WT, Briehl MM, and Powis G. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res 62: 5089-5095, 2002.
51. Wo YY, McCormack AL, Shabanowitz J, Hunt DF, Davis JP, Mitchell GL, and Van Etten RL. Sequencing, cloning, and expression of human red cell-type acid phosphatase, a cytoplasmic phosphotyrosyl protein phosphatase. J Biol Chem 267: 10856-10865, 1992.
52. Wu Z, Hofman FM, and Zlokovic BV. A simple method for isolation and characterization of mouse brain microvascular endothelial cells. J Neurosci Methods 130: 53-63, 2003.
53. Xing K, Raza A, Lofgren S, FernandoMR, Ho YS, and LouMF. Low molecular weight protein tyrosine phosphatase (LMWPTP) and its possible physiological functions of redox signaling in the eye lens. Biochim Biophys Acta 1774: 545-555, 2007.